Stock Events

Stock Events

Terns Pharmaceuticals (TERN) Q2 2024 Earnings

13MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.42

-0.36

-0.31

-0.25

Details

Expected EPS

-0.346469

Actual EPS

-0.3

Surprise EPS

0.05

Surprise Percent

+13.41%

Description

Terns Pharmaceuticals (TERN) has reported earnings of -0.3 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.